Cover of publication SOP Improving environmental protection in EU pharmaceutical legislation
Chemicals

Improving environmental protection in EU pharmaceutical legislation

Recommendations for reducing adverse environmental impacts from human pharmaceuticals


In preparation of the revision of Directive 2001/83/ EC and Regulation (EC) No 726/2004, the German Environment Agency (UBA) proposes legal changes to reduce pharmaceutical residues in the environment. The proposals are based on UBA’s experiences as competent authority for the environmental risk assessment (ERA) of pharmaceuticals. Our overall aim is to ensure a comprehensive risk management system without compromising availability of medicines for patients. In this context we consider the recent EU strategy on pharmaceuticals and initiatives in connection with EU`s Green Deal particularly the Zero Pollution Ambition and the one substance one assessment approach.

Series
Scientific Opinion Paper
Number of pages
23
Year of publication
Author(s)
Daniela Gildemeister, Annika Buck, Arne Hein; Ines Rönnefahrt, Ina Ebert, Małgorzata Dębiak
Language
English
Publisher
Umweltbundesamt
File size
1011 KB
Price
0,00 €
Print version
not available
rated as helpful
25
Share:
Article:
Printer-friendly version
Tags:
 pharmaceuticals  environmental risk assessment